Conmed (CNMD) Operating Expenses (2010 - 2026)

Conmed has reported Operating Expenses for 17 years, with the latest figure at $158.0 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 2.33% year-over-year to $158.0 million; the trailing twelve-month figure through Mar 2026 stood at $644.1 million (up 15.52% YoY), and the FY2025 full-year result was $647.9 million, up 21.62% from the prior year.
• Operating Expenses for Q1 2026 stood at $158.0 million, down from $181.7 million in the prior quarter.
• The five-year high for Operating Expenses was $181.7 million in Q4 2025, with the low at $113.3 million in Q3 2024.
• Historically, Operating Expenses has averaged $140.9 million across 5 years, with a median of $137.8 million in 2023.
• Annual changes were most pronounced in 2024 — Operating Expenses fell 17.76% — and 2025, when it surged 36.15%.
• Conmed's Operating Expenses stood at $133.0 million in 2022, then retreated by 0.73% to $132.0 million in 2023, then climbed by 10.5% to $145.8 million in 2024, then climbed by 24.56% to $181.7 million in 2025, then fell by 13.01% to $158.0 million in 2026.
• The last three Operating Expenses figures came in at $158.0 million (Q1 2026), $181.7 million (Q4 2025), and $154.2 million (Q3 2025), per Business Quant data.